Hoon DS - Search Results

1

Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.

Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Wang HJ, Elashoff RM, Takeuchi H, Umetani N, Hoon DS. Koyanagi K, et al. Among authors: hoon ds. J Clin Oncol. 2005 Nov 1;23(31):8057-64. doi: 10.1200/JCO.2005.02.0958. J Clin Oncol. 2005. PMID: 16258104 Free PMC article.

2

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

Morton DL, Foshag LJ, Hoon DS, Nizze JA, Famatiga E, Wanek LA, Chang C, Davtyan DG, Gupta RK, Elashoff R, et al. Morton DL, et al. Among authors: hoon ds. Ann Surg. 1992 Oct;216(4):463-82. doi: 10.1097/00000658-199210000-00010. Ann Surg. 1992. PMID: 1417196 Free PMC article. Clinical Trial.

3

Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.

Hoon DS, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, Kuo C, Foshag LJ, Nizze AJ, Morton DL. Hoon DS, et al. J Clin Oncol. 1995 Aug;13(8):2109-16. doi: 10.1200/JCO.1995.13.8.2109. J Clin Oncol. 1995. PMID: 7636555 Clinical Trial.

4

Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma.

Morton DL, Hoon DS, Nizze JA, Foshag LJ, Famatiga E, Wanek LA, Chang C, Irie RF, Gupta RK, Elashoff R. Morton DL, et al. Among authors: hoon ds. Ann N Y Acad Sci. 1993 Aug 12;690:120-34. doi: 10.1111/j.1749-6632.1993.tb44002.x. Ann N Y Acad Sci. 1993. PMID: 8368731 Clinical Trial. No abstract available.

5

Melanoma-associated antigens as messenger RNA detection markers for melanoma.

Sarantou T, Chi DD, Garrison DA, Conrad AJ, Schmid P, Morton DL, Hoon DS. Sarantou T, et al. Among authors: hoon ds. Cancer Res. 1997 Apr 1;57(7):1371-6. Cancer Res. 1997. PMID: 9102226

6

Prognostic implications of p53 overexpression in cutaneous melanoma from sun-exposed and nonexposed sites.

Essner R, Kuo CT, Wang H, Wen DR, Turner RR, Nguyen T, Hoon DS. Essner R, et al. Among authors: hoon ds. Cancer. 1998 Jan 15;82(2):309-16. doi: 10.1002/(sici)1097-0142(19980115)82:2<317::aid-cncr10>3.0.co;2-1. Cancer. 1998. PMID: 9445187

7

Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma.

Kuo CT, Bostick PJ, Irie RF, Morton DL, Conrad AJ, Hoon DS. Kuo CT, et al. Among authors: hoon ds. Clin Cancer Res. 1998 Feb;4(2):411-8. Clin Cancer Res. 1998. PMID: 9516930

8

Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients?

Hoon DS, Okamoto T, Wang HJ, Elashoff R, Nizze AJ, Foshag LJ, Gammon G, Morton DL. Hoon DS, et al. J Clin Oncol. 1998 Apr;16(4):1430-7. doi: 10.1200/JCO.1998.16.4.1430. J Clin Oncol. 1998. PMID: 9552048

9

Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DS. Bostick PJ, et al. Among authors: hoon ds. J Clin Oncol. 1998 Aug;16(8):2632-40. doi: 10.1200/JCO.1998.16.8.2632. J Clin Oncol. 1998. PMID: 9704713

10

Augmentation of IgM antibody to gp43 tumor-associated antigen peptide by melanoma cell vaccine.

Takahashi T, Conforti A, Kikumoto Y, Hoon DS, Morton DL, Irie RF. Takahashi T, et al. Among authors: hoon ds. J Clin Immunol. 1998 Jul;18(4):299-305. doi: 10.1023/a:1027342024618. J Clin Immunol. 1998. PMID: 9710747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters